Document ID: chunk:federal_register_of_legislation:F2024C00897:body:0:p12
Version: federal_register_of_legislation:F2024C00897
Segment Type: other
Provision Reference: 
Character Range: 31417–34723

with section 2.9.1—24.

            (3) If the statement includes the *average quantity of a permitted nutritive substance, an *inulin-type fructan or a *galacto-oligosaccharide, that average quantity must be included in the statement:

               (a) under the subheading 'Additional'; and
               (b) in the same format as specified in the table for that substance.

            (4) If the statement includes the *average quantity of choline, inositol or L-carnitine, that average quantity must be included in the statement:

               (a) for infant formula—under the subheading 'Other nutrients'; and
               (b) for follow-on formula—under the subheading 'Additional'; and
               (c) in the same format as specified in the table for that substance.

            (5) If the statement includes the *average quantity of a substance listed in subsection 2.9.1—24(4), that average quantity must be included in the statement in the same format as specified in the table for that substance.

            (6) If the statement includes the *average quantity of the substances listed in subsection 2.9.1—24(5), the statement:

               (a) must include the subheading 'Long chain polyunsaturated fatty acids' that is printed in a size of type that is the same or larger than the nutrient names in the statement; and

               (b) must include that average quantity:

                   (i) under the subheading 'Long chain polyunsaturated fatty acids'; and
                   (ii) in the same format as specified in the table for those substances; and

               (c)   must use the name for each substance specified in the table for that substance; and

               (d)  may use the acronym specified in the table for the following substances in addition to the name required for those substances by paragraph (c):

              (i) docosahexaenoic acid; and
                   (ii)  eicosapentaenoic acid; and
  (iii)  arachidonic acid.
                      Example The statement may use 'Docosahexaenoic acid (DHA)' or 'Docosahexaenoic acid', but not 'DHA'.

            (7) If the statement includes information expressed in accordance with subsection 2.9.1—24(7), that information must be in an additional column at the right hand side of the column shown in the table.

            (8) Information included in the additional column required by subsection (7) must be in the form required by this section.

               Note  For an example nutrition information statement including information expressed in accordance with subsection 2.9.1—24(7), see section S29—10A.

           2.9.1—26 How average quantity is to be calculated

             Despite section 1.1.1—6, the method in paragraph 1.1.1—6(3)(c) must not be used to calculate the *average quantity of a substance in infant formula or follow‑on formula.

           2.9.1—27 Requirements for use of stage numbers

            (1) The following numbers may be used on the label on a package of infant formula or follow-on formula to identify for consumers that the product is infant formula or follow‑on formula:

               (a) if the product is infant formula—the number '1'; and
               (b) if the product is follow-on formula—the number '2'.

            (2) A number used in